CORLOPAM Drug Patent Profile
✉ Email this page to a colleague
When do Corlopam patents expire, and when can generic versions of Corlopam launch?
Corlopam is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in CORLOPAM is fenoldopam mesylate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fenoldopam mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Corlopam
A generic version of CORLOPAM was approved as fenoldopam mesylate by HIKMA on October 12th, 2004.
Summary for CORLOPAM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 74 |
| Clinical Trials: | 5 |
| Patent Applications: | 676 |
| Drug Prices: | Drug price information for CORLOPAM |
| What excipients (inactive ingredients) are in CORLOPAM? | CORLOPAM excipients list |
| DailyMed Link: | CORLOPAM at DailyMed |
Recent Clinical Trials for CORLOPAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bambino Gesù Hospital and Research Institute | Phase 3 |
| IRCCS Policlinico S. Donato | Phase 4 |
| Università Vita-Salute San Raffaele | Phase 3 |
Pharmacology for CORLOPAM
| Drug Class | Dopaminergic Agonist |
| Mechanism of Action | Dopamine Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for CORLOPAM
US Patents and Regulatory Information for CORLOPAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | CORLOPAM | fenoldopam mesylate | INJECTABLE;INJECTION | 019922-001 | Sep 23, 1997 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
